Owing to Covid-19 pandemic and the lock-down conditions, the work relating to regulatory approvals got affected and delayed beyond 31 May 2021, though significant progress was achieved in this regard. An amount of Rs 225 crore has already been received by the Company as on 30 April 2021. The balance consideration will be received on obtaining aforesaid regulatory approvals and payment milestones.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content